282 related articles for article (PubMed ID: 10049671)
1. Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies.
Anderson M; Blowers D; Hewitt N; Hedge P; Breeze A; Hampton I; Taylor I
Protein Expr Purif; 1999 Mar; 15(2):162-70. PubMed ID: 10049671
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
Boismenu R; Semeniuk D; Murgita RA
Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
[TBL] [Abstract][Full Text] [Related]
3. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
García-Sáez AJ; Mingarro I; Pérez-Payá E; Salgado J
Biochemistry; 2004 Aug; 43(34):10930-43. PubMed ID: 15323553
[TBL] [Abstract][Full Text] [Related]
4. Pore formation domain of human pro-apoptotic Bax induces mammalian apoptosis as well as bacterial death without antagonizing anti-apoptotic factors.
Ishibashi Y; Nishimaki K; Asoh S; Nanbu-Wakao R; Yamada T; Ohta S
Biochem Biophys Res Commun; 1998 Feb; 243(2):609-16. PubMed ID: 9480856
[TBL] [Abstract][Full Text] [Related]
5. High-yield expression and purification of soluble forms of the anti-apoptotic Bcl-x(L) and Bcl-2 as TolAIII-fusion proteins.
Nedelkina S; Gokce I; Ridley H; Weckerle C; Magnin T; Vallette F; Pattus F; Lakey JH; Bechinger B
Protein Expr Purif; 2008 Aug; 60(2):214-20. PubMed ID: 18522870
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2.
Chang BS; Minn AJ; Muchmore SW; Fesik SW; Thompson CB
EMBO J; 1997 Mar; 16(5):968-77. PubMed ID: 9118958
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli.
Banerji S; Day AJ; Kahmann JD; Jackson DG
Protein Expr Purif; 1998 Dec; 14(3):371-81. PubMed ID: 9882571
[TBL] [Abstract][Full Text] [Related]
8. Heterodimeric CD3epsilongamma extracellular domain fragments: production, purification and structural analysis.
Kim KS; Sun ZY; Wagner G; Reinherz EL
J Mol Biol; 2000 Sep; 302(4):899-916. PubMed ID: 10993731
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human cytomegalovirus protease with a C-terminal (His)6 extension: purification, autocatalytic release of the mature enzyme, and biochemical characterization.
Tomasselli AG; Paddock DJ; Curry KA; Garlick RL; Leone JW; Lull JM; Mutchler VT; Baker CA; Cavey GS; Mathews WR; Shelly JA; Finzel BC; Baldwin ET; Wells PA; Tomich CS
Protein Expr Purif; 1998 Dec; 14(3):343-52. PubMed ID: 9882568
[TBL] [Abstract][Full Text] [Related]
10. Purification and biochemical properties of soluble recombinant human Bax.
Lewis S; Bethell SS; Patel S; Martinou JC; Antonsson B
Protein Expr Purif; 1998 Jun; 13(1):120-6. PubMed ID: 9631524
[TBL] [Abstract][Full Text] [Related]
11. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.
Muchmore SW; Sattler M; Liang H; Meadows RP; Harlan JE; Yoon HS; Nettesheim D; Chang BS; Thompson CB; Wong SL; Ng SL; Fesik SW
Nature; 1996 May; 381(6580):335-41. PubMed ID: 8692274
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Bax-sigma, a cell death-inducing isoform of Bax.
Schmitt E; Paquet C; Beauchemin M; Dever-Bertrand J; Bertrand R
Biochem Biophys Res Commun; 2000 Apr; 270(3):868-79. PubMed ID: 10772918
[TBL] [Abstract][Full Text] [Related]
13. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
14. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
Lindenboim L; Yuan J; Stein R
Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
[TBL] [Abstract][Full Text] [Related]
15. Expression and purification of full-length human Bax alpha.
Montessuit S; Mazzei G; Magnenat E; Antonsson B
Protein Expr Purif; 1999 Mar; 15(2):202-6. PubMed ID: 10049676
[TBL] [Abstract][Full Text] [Related]
16. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
Afzal AJ; Lightfoot DA
Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
[TBL] [Abstract][Full Text] [Related]
17. Expression and purification of full-length anti-apoptotic Bcl-2 using cell-free protein synthesis.
Pedersen A; Wallgren M; Karlsson BG; Gröbner G
Protein Expr Purif; 2011 Jun; 77(2):220-3. PubMed ID: 21315822
[TBL] [Abstract][Full Text] [Related]
18. Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin.
Wan L; Zeng L; Chen L; Huang Q; Li S; Lu Y; Li Y; Cheng J; Lu X
Protein Expr Purif; 2006 Aug; 48(2):307-13. PubMed ID: 16584889
[TBL] [Abstract][Full Text] [Related]
19. Pro-apoptotic activity of transiently expressed BCL-2 occurs independent of BAX and BAK.
Subramanian T; Chinnadurai G
J Cell Biochem; 2003 Aug; 89(6):1102-14. PubMed ID: 12898509
[TBL] [Abstract][Full Text] [Related]
20. Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies.
Medynski D; Tuan M; Liu W; Wu S; Lin X
Protein Expr Purif; 2007 Apr; 52(2):395-402. PubMed ID: 17126563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]